FDA Authorizes First Vaccine for Respiratory Syncytial Virus (RSV) to Protect Infants and Elders
The US Food and Drug Administration (FDA) has authorized its first vaccine for respiratory syncytial virus (RSV), a common respiratory virus that can lead to fatal consequences for infants or elders. The vaccine, called Arexvy and developed by GlaxoSmithKline (GSK), is approved for those 60 or older and has an efficiency rate of 82.6% in preventing confirmed lower respiratory tract illness brought on by RSV, according to results from a phase 3 clinical investigation.
The Centers for Disease Control and Prevention (CDC) must support immunizations before the vaccine is pushed into the market, and the Advisory Committee on Immunization Practices (APIC) is expected to approve it during its June 21 to 22 meeting. The FDA is also expected to approve a vaccine for infants under six months of age later this year, and a Sanofi-marketed antibody therapy is also expected to receive clearance soon. RSV is the second most common cause of death for young children worldwide after malaria.
While there is no cure for RSV infection, the symptoms generally improve independently. However, it is crucial to seek advice from a medical professional if symptoms persist, along with staying hydrated and getting good rest.
IJCP Editorial Team
Comprising seasoned professionals and experts from the medical field, the IJCP editorial team is dedicated to delivering timely and accurate content and thriving to provide attention-grabbing information for the readers. What sets them apart are their diverse expertise, spanning academia, research, and clinical practice, and their dedication to upholding the highest standards of quality and integrity. With a wealth of experience and a commitment to excellence, the IJCP editorial team strives to provide valuable perspectives, the latest trends, and in-depth analyses across various medical domains, all in a way that keeps you interested and engaged.
More FAQs by IJCP Editorial Team
Medtalks is India's fastest growing Healthcare Learning and Patient Education Platform designed and developed to help doctors and other medical professionals to cater educational and training needs and to discover, discuss and learn the latest and best practices across 100+ medical specialties. Also find India Healthcare Latest Health News & Updates on the India Healthcare at Medtalks
Please login to comment on this article